Clinical Research for the Treatment of Atomization Inhalation of Budesonide Suspension Combined Ventolin Liquid to Acute Aggravating Period of COPD
Objective:To study the clinical treatment of atomization inhalation of budesonide suspension combined ventolin liquid to acute Aggravating Period of COPD.Methods:Make the 56 patients with AECOPD in our hospital departments between June 2012 and September 2013 as the research object.Patients randomly divided into control group and observation group and control group in 28 patients were treated with conventional,28 patients in the observation group,on the basis of conventional treatment,using atomizing inhalation budesonide suspension liquid combined ventolin liquid adjuvant theraG py.Result:After the treatment,two groups of patients with pulmonary functions and dyspnea than before treatment was obviously improved.Compared with the control group and observation group of paG tients with better treatment ef ect is obvious,significant dif erence comparing the two groups(P>0.05),with statistical significance.During the treatment,observation group of patients without any discomG fort or severe complications.Conclusion:Treat the patients with COPD in acute aggravating period using atomizing inhalation budesonide suspension liquid combined ventolin liquid can obtain ideal treatment ef ect,high safety,suitable for clinical application.
NETL
NSTL
万方数据
